Donanemab is a medication being studied for its potential to help people with early symptoms of Alzheimer’s disease. It works by targeting and removing a protein called amyloid that builds up in the brains of people with Alzheimer’s. This buildup is thought to contribute to the symptoms of the disease. The trial is looking at different ways of giving this medication to see which method is most effective at reducing the buildup of amyloid and minimizing side effects, particularly a condition known as ARIA-E, which can cause swelling in the brain.

Neurocognitive Disorders – These are a group of disorders characterized by a decline in cognitive function, which can affect memory, attention, learning, language, and decision-making. The progression often involves a gradual worsening of cognitive abilities, impacting daily activities and independence. Symptoms may start subtly and become more noticeable over time, leading to significant impairment in social and occupational functioning.

Central Nervous System Diseases – These diseases affect the brain and spinal cord, leading to a variety of symptoms depending on the specific condition. Progression can vary widely, with some diseases causing gradual deterioration of neurological function, while others may have sudden onset. Symptoms can include motor dysfunction, sensory disturbances, and cognitive impairments.

Neurodegenerative Diseases – These are characterized by the progressive degeneration of nerve cells, leading to a decline in motor and cognitive functions. The progression is typically slow and irreversible, with symptoms worsening over time. Common features include memory loss, movement disorders, and changes in behavior and personality.

Nervous System Diseases – These encompass a wide range of conditions affecting the nervous system, including the brain, spinal cord, and peripheral nerves. Progression can be acute or chronic, with symptoms such as pain, weakness, numbness, and cognitive changes. The impact on daily life can vary from mild to severe, depending on the specific disease.

Dementia – This is a syndrome characterized by a decline in cognitive function beyond what might be expected from normal aging. It progresses gradually, affecting memory, thinking, orientation, comprehension, calculation, learning capacity, language, and judgment. As it advances, it can lead to a loss of ability to perform everyday activities.

Alzheimer’s Disease – A type of dementia that involves the progressive loss of memory and other cognitive functions. It typically begins with mild memory loss and confusion, eventually leading to severe cognitive and functional impairments. The disease progresses over several years, affecting language, reasoning, and the ability to perform simple tasks.

Brain Diseases – These include a variety of conditions that affect the structure and function of the brain. Progression can be rapid or slow, depending on the specific disease, and can lead to symptoms such as headaches, seizures, cognitive decline, and changes in behavior. The impact on an individual’s life can range from mild to debilitating.

Mental Disorders – These are conditions that affect mood, thinking, and behavior, and can include depression, anxiety disorders, schizophrenia, and bipolar disorder. Progression varies widely, with some disorders being episodic and others chronic. Symptoms can interfere with daily functioning and relationships, and may fluctuate in severity over time.